OMEGA PHARMA BELGIUM
Summary
OMEGA PHARMA BELGIUM is registered in Belgium and entered in the “Crossroads Bank for Enterprises (KBO/BCE)” under number 0417132860. Its legal form is Naamloze vennootschap (NV) – public limited company (Belgium). According to GLEIF, its ultimate parent is PERRIGO COMPANY PUBLIC LIMITED COMPANY (Ireland), which is also its direct parent. That group has 9 subsidiaries with LEIs in 4 countries, 4 of them in Belgium. The LEI was first issued on 25 Mar 2021 and the record was last updated on 26 Mar 2025. It has lapsed: renewal was due by 25 Mar 2025. GLEIF's ISIN mapping lists 1 ISIN for this LEI. AssetCensus found 3 data-quality notes for this entity (see below).
Written from GLEIF data using fixed, reviewed sentence templates.
Data-quality notes (AssetCensus analysis)
- The LEI has lapsed: it was due for renewal by 25 Mar 2025 and was not renewed, so GLEIF's data for this entity has not been re-verified since. A lapsed LEI does not mean the company has ceased to exist.
- The ultimate-parent link rests on accounts for the period ending 31 Dec 2022, more than 24 months before this data release. The group may have changed since.
- The ultimate-parent relationship record was not renewed; it was last updated on 26 Mar 2025.
Company details
| Legal form | Naamloze vennootschap (NV) public limited company (Belgium) |
|---|---|
| Register | Crossroads Bank for Enterprises (KBO/BCE) · Register website |
| Registration number | 0417132860 |
| Registration authority | Federal Public Service Economy (Ministry of Economy) |
| Jurisdiction | Belgium |
| Registered address | Venecoweg 26, 9810 Nazareth, Belgium |
| Category | company or other legal entity |
| Status | active |
| Founded (per GLEIF) | 5 May 1977 |
| LEI | 699400OM0TR7QPJXCY11 |
| LEI status | lapsed |
| LEI first issued | 25 Mar 2021 |
| LEI record last updated | 26 Mar 2025 |
| Next LEI renewal | 25 Mar 2025 |
| Corroboration of the LEI record | fully corroborated |
Group membership
Relationship to the parent
| Direct parent | Ultimate parent | |
|---|---|---|
| Parent | PERRIGO COMPANY PUBLIC LIMITED COMPANY | PERRIGO COMPANY PUBLIC LIMITED COMPANY |
| Accounting period | 1 Jan 2022 to 31 Dec 2022 | 1 Jan 2022 to 31 Dec 2022 |
| Evidence | consolidated accounts | consolidated accounts |
| Corroboration | fully corroborated | fully corroborated |
| Accounting standard | US GAAP | US GAAP |
| Relationship start | 1 Jan 2019 | 1 Jan 2019 |
| Recorded at GLEIF since | 25 Mar 2021 | 25 Mar 2021 |
| Last updated | 26 Mar 2025 | 26 Mar 2025 |
| Record status | not renewed | not renewed |
Other subsidiaries of the same direct parent (8)
- OMEGA PHARMA INVEST NV Belgium lapsed
- OMEGA PHARMA NV Belgium lapsed
- PERRIGO CAPITAL Belgium
- GALPHARM INTERNATIONAL LIMITED United Kingdom
- PERRIGO FINANCE UNLIMITED COMPANY Ireland
- Perrigo Investments, LLC United States
- PERRIGO UK ACQUISITION LIMITED United Kingdom
- WRAFTON LABORATORIES LIMITED United Kingdom
ISINs mapped to this LEI (1)
BE0127820711
1 in the GLEIF–ANNA mapping file. The file covers ISINs issued since the mapping started, not all securities.